Mark Sinyor, MD

  • 4Articles
  • 18.5KReads1
  • 2010–2023Active
  • 17Collaborators
  • 203Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Mark Sinyor, MD, is affiliated with the Department of Psychiatry at the University of Toronto and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada. His publications from 2010 to 2023 focus on clinical topics including major depressive disorder, bipolar disorder, child and adolescent psychiatry, and suicide. His research has addressed risk-sensitive decision-making and self-harm in youth with bipolar disorder, suicide in schizophrenia based on coroner records, and factors influencing antidepressant treatment outcomes in randomized controlled trials. He has frequently collaborated with co-authors such as Ayal Schaffer and Anthony J. Levitt.

Publications

JCP
Risk-Sensitive Decision-Making and Self-Harm
Original Research

Risk-Sensitive Decision-Making and Self-Harm

September 6, 2023

Greater risk-taking has been associated with suicide attempts in youth with major depression. This study examined whether the association between self-harm and risk-sensitive decision-making is true for bipolar disorder...
, , , et al
JCP
Original Research

Suicide in Schizophrenia: An Observational Study of Coroner Records in Toronto

January 28, 2015

, ,
JCP
Review Article

Sponsorship, Antidepressant Dose, and Outcome in Major Depressive Disorder: Meta-Analysis of Randomized Controlled Trials

February 15, 2012

, , , et al
JCP
Original Research

Does Inclusion of a Placebo Arm Influence Response to Active Antidepressant Treatment in Randomized Controlled Trials? Results From Pooled and Meta-Analyses

January 26, 2010

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe